Esomeprazole for prevention and resolution of upper gastrointestinal symptoms in patients treated with low-dose acetylsalicylic acid for cardiovascular protection: the OBERON trial - Scheiman, J M; Herlitz, J; Veldhuyzen van Zanten, S J (J Cardiovasc Pharmacol, 2013)
et al.